Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ULTIMATE SACRIFICE

NPI: 1568050573 · WINSTON SALEM, NC 27105 · Clinical Social Worker · NPI assigned 01/05/2021

$709K
Total Medicaid Paid
8,750
Total Claims
4,080
Beneficiaries
4
Codes Billed
2023-08
First Month
2024-07
Last Month

Provider Details

Authorized OfficialHOYLE, JASMINE (CEO)
NPI Enumeration Date01/05/2021

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2023 3,862 $344K
2024 4,888 $365K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 2,908 1,351 $405K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,903 1,356 $177K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,918 1,359 $127K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 21 14 $0.00